Genentech Manufacturing Deal With Lonza Provides For Future Biologic Expansion
This article was originally published in The Pink Sheet Daily
Executive Summary
Genentech plans to sell its 40,000-liter facility in Spain to Lonza, while in turn gaining the option to buy Lonza’s 80,000-liter facility in Singapore.